James M. Oliphant Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

National Center for Toxicological Research

faculty

5 h-index 13 pubs 207 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

James M. Oliphant's research focuses on the application of metabolomics and lipidomics to identify biomarkers for disease severity, particularly in the context of COVID-19. He also investigates the development and validation of alternative methods for toxicity screening, such as liver-on-a-chip platforms, and the use of New Approach Methodologies (NAMs) for drug development. Additionally, Oliphant's work extends to plant science, including the characterization of crop cultivars under controlled lighting conditions and the development of climate scenarios for germplasm maintenance of berry crops. His scholarship includes 13 publications and has been cited 207 times, with an h-index of 5. His collaborations are primarily with researchers at the National Center for Toxicological Research.

Metrics

  • h-index: 5
  • Publications: 13
  • Citations: 207

Selected Publications

  • Challenges and solutions in measuring commonly used biomarkers for drug-induced liver injury in a liver-on-a-chip platform (2025) DOI
  • Validating and Using Cardiac NAMs for Toxicity Screening and Drug Development (2025) DOI
  • Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers (2024) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics